PERSPECTA

News from every angle

← Back to headlines

Analyst Bullish on Beam Therapeutics Over Drug Program Trajectory

An analyst expresses a bullish sentiment on Beam Therapeutics (BEAM) due to the promising trajectory of its drug programs.

19 Feb, 00:39 — 19 Feb, 00:39
PostShare
Only 1 source covers this story